{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T18:22:42Z","timestamp":1768674162547,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy in the pediatric population. The manifestations of this disease include progressive muscle weakness, gait dysfunction, and motor impairment, leading to a loss of ambulation by the age of 13\u2009years. Molecular diagnosis is the standard diagnostic tool for DMD. This study aimed to investigate disease progression and genetic patterns in Iranian ambulant boys and to find the correlation between genotypes and motor function phenotypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study was performed on 152 DMD patients. Clinical history, including the disease phenotype, steroid therapy, and the North Star Ambulatory Assessment (NSAA) score, was taken for all the patients. Molecular diagnoses were confirmed by multiplex ligation-dependent probe amplification and next-generation sequencing tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 152 Iranian DMD patients were examined in this study. The mean age at the time of disease onset was 4.04\u2009\u00b1\u20092.00\u2009years, and the mean age at diagnosis was 5.05\u2009\u00b1\u20092.08\u2009years. The mean age of ambulation loss was 10.9\u2009years. Contracture was reported in 38.9% of cases. In terms of age, the mean total NSAA score showed a peak at 4 years of age, with a mean NSAA score of 24. Annual changes in the NSAA score were determined for all cases, based on the mutation type and exon site. Deletion mutation was found in 79.1% of cases, duplication in 6.8%, nonsense in 12.8%, and splice site in 1.4%. The most common single exon deletion was exon 44 (5.3%), and the most common multiexon deletions were attributed to exons 45\u201350 and exons 45\u201352 (4.6%). The results did not indicate any correlation between the mutation type and age at the time of disease onset, loss of ambulation age, and wheelchair dependence; however, a significant association was found between contracture and mutation type. The results showed a significant difference in the NSAA score between the deletion and nonsense groups at the age of 3 years (<jats:italic>P<\/jats:italic>\u2009=\u20090.04). No significant correlation was found between the phenotype and exon site. Overall, 91.1% of the study population had a history of corticosteroid use, and 54.1% showed compliance with rehabilitation therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study demonstrated the phenotypes and mutational features of Iranian DMD boys and provided information regarding the natural motor history of the disease, disease progression, diagnosis, and status of DMD management in Iran. The present findings can promote the development of clinical trials and future advanced molecular therapies in Iran.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02687-1","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T18:02:42Z","timestamp":1651514562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"22","author":[{"given":"Gholamreza","family":"Zamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sareh","family":"Hosseinpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud Reza","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza Shervin","family":"Badv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Reza","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masood Ghahvechi","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Hosseini","family":"Bereshneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza Azizi","family":"Malamiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7487-569X","authenticated-orcid":false,"given":"Morteza","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"issue":"3","key":"2687_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmedgenet-2015-103387","volume":"53","author":"A Aartsma-Rus","year":"2016","unstructured":"Aartsma-Rus A, Ginjaar IB, Bushby K. The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet. 2016;53(3):145\u201351.","journal-title":"J Med Genet"},{"issue":"4","key":"2687_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1212\/WNL.0000000000002891","volume":"87","author":"L Bello","year":"2016","unstructured":"Bello L, Morgenroth LP, Gordish-Dressman H, Hoffman EP, McDonald CM, Cirak S. DMD genotypes and loss of ambulation in the CINRG Duchenne natural history study. Neurology. 2016;87(4):401\u20139.","journal-title":"Neurology"},{"issue":"2","key":"2687_CR3","doi-asserted-by":"publisher","first-page":"e4347","DOI":"10.1371\/journal.pone.0004347","volume":"4","author":"I Desguerre","year":"2009","unstructured":"Desguerre I, Christov C, Mayer M, Zeller R, Becane H-M, Bastuji-Garin S, et al. Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One. 2009;4(2):e4347.","journal-title":"PLoS One"},{"issue":"4","key":"2687_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jpm8040041","volume":"8","author":"Y Echigoya","year":"2018","unstructured":"Echigoya Y, Lim KRQ, Nakamura A, Yokota T. Multiple exon skipping in the duchenne muscular dystrophy hot spots: prospects and challenges. J Pers Med. 2018;8(4):41.","journal-title":"J Pers Med"},{"issue":"2","key":"2687_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12041-016-0641-2","volume":"95","author":"M Haghshenas","year":"2016","unstructured":"Haghshenas M, Akbari MT, Karizi SZ, Deilamani FK, Nafissi S, Salehi Z. Evaluation of point mutations in dystrophin gene in Iranian Duchenne and Becker muscular dystrophy patients: introducing three novel variants. J Genet. 2016;95(2):325\u20139.","journal-title":"J Genet"},{"key":"2687_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/978-94-011-1528-5_2","volume-title":"Genotype\/phenotype correlations in Duchenne\/Becker dystrophy. Molecular and cell biology of muscular dystrophy","author":"EP Hoffman","year":"1993","unstructured":"Hoffman EP. Genotype\/phenotype correlations in Duchenne\/Becker dystrophy. Molecular and cell biology of muscular dystrophy: Springer; 1993. p. 12\u201336."},{"issue":"8","key":"2687_CR7","doi-asserted-by":"publisher","first-page":"e0135189","DOI":"10.1371\/journal.pone.0135189","volume":"10","author":"J Juan-Mateu","year":"2015","unstructured":"Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ, Baena M, Verdura E, Nascimento A, et al. DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations. PLoS One. 2015;10(8):e0135189.","journal-title":"PLoS One"},{"issue":"2","key":"2687_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.pedneo.2017.02.004","volume":"59","author":"W-C Liang","year":"2018","unstructured":"Liang W-C, Wang C-H, Chou P-C, Chen W-Z, Jong Y-J. The natural history of the patients with Duchenne muscular dystrophy in Taiwan: a medical center experience. Pediatr Neonatol. 2018;59(2):176\u201383.","journal-title":"Pediatr Neonatol"},{"issue":"9","key":"2687_CR9","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1007\/s00415-011-5979-z","volume":"258","author":"F Magri","year":"2011","unstructured":"Magri F, Govoni A, D\u2019Angelo MG, Del Bo R, Ghezzi S, Sandra G, et al. Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J Neurol. 2011;258(9):1610\u201323.","journal-title":"J Neurol"},{"key":"2687_CR10","first-page":"CD003725","volume":"1","author":"AY Manzur","year":"2008","unstructured":"Manzur AY, Kuntzer T, Pike M, Swan AV. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2008;1:CD003725.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2687_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ejhg.2012.269","volume":"21","author":"S Mercier","year":"2013","unstructured":"Mercier S, Toutain A, Toussaint A, Raynaud M, De Barace C, Marcorelles P, et al. Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age. Eur J Hum Genet. 2013;21(8):855\u201363.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"2687_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0022-510X(98)00051-3","volume":"157","author":"A Mital","year":"1998","unstructured":"Mital A, Kumari D, Gupta M, Goyle S. Molecular characterisation of Duchenne muscular dystrophy and phenotypic correlation. J Neurol Sci. 1998;157(2):179\u201386.","journal-title":"J Neurol Sci"},{"key":"2687_CR13","first-page":"32","volume":"105","author":"B Mittal","year":"1997","unstructured":"Mittal B, Singh V, Mishra S, Sinha S, Mittal R, Chaturvedi L, et al. Genotype-phenotype correlation in Duchenne\/Becker muscular dystrophy patients seen at Lucknow. Indian J Med Res. 1997;105:32\u20138.","journal-title":"Indian J Med Res"},{"issue":"9","key":"2687_CR14","doi-asserted-by":"publisher","first-page":"e0221097","DOI":"10.1371\/journal.pone.0221097","volume":"14","author":"F Muntoni","year":"2019","unstructured":"Muntoni F, Domingos J, Manzur AY, Mayhew A, Guglieri M, Network UN, et al. Categorising trajectories and individual item changes of the north star ambulatory assessment in patients with Duchenne muscular dystrophy. PLoS One. 2019;14(9):e0221097.","journal-title":"PLoS One"},{"key":"2687_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fgene.2020.00131","volume":"11","author":"M Neri","year":"2020","unstructured":"Neri M, Rossi R, Trabanelli C, Mauro A, Selvatici R, Falzarano MS, et al. The genetic landscape of dystrophin mutations in Italy: a nationwide study. Front Genet. 2020;11:131.","journal-title":"Front Genet"},{"issue":"4","key":"2687_CR16","first-page":"607","volume":"11","author":"L Peddareddygari","year":"2011","unstructured":"Peddareddygari L, Pillai B, Nochlin D, Sharer L, Grewal R. Phenotype-genotype analysis of dystrophinopathy caused by duplication mutation in Dystrophin gene in an African patient. Afr Health Sci. 2011;11(4):607\u20139.","journal-title":"Afr Health Sci"},{"issue":"2","key":"2687_CR17","first-page":"149","volume":"87","author":"V Ricotti","year":"2016","unstructured":"Ricotti V, Ridout DA, Pane M, Main M, Mayhew A, Mercuri E, et al. The NorthStar ambulatory assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials. J Neurol Neurosurg Psychiatry. 2016;87(2):149\u201355.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2687_CR18","first-page":"303","volume":"132","author":"S Sakthivel Murugan","year":"2010","unstructured":"Sakthivel Murugan S, Chandramohan A, Lakshmi BR. Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis. Indian J Med Res. 2010;132:303\u201311.","journal-title":"Indian J Med Res"},{"issue":"1","key":"2687_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpn.2013.08.008","volume":"18","author":"E Sarrazin","year":"2014","unstructured":"Sarrazin E, von der Hagen M, Schara U, von Au K, Kaindl AM. Growth and psychomotor development of patients with Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2014;18(1):38\u201344.","journal-title":"Eur J Paediatr Neurol"},{"key":"2687_CR20","doi-asserted-by":"publisher","first-page":"100641","DOI":"10.1016\/j.mgene.2019.100641","volume":"23","author":"G Shariati","year":"2020","unstructured":"Shariati G, Shakerian S, Anaie MM, Abdorasouli N, Nanvazadeh F, Sedaghat A, et al. Deletion and duplication mutations spectrum in Duchenne muscular dystrophy in the southwest of Iran. Meta Gene. 2020;23:100641.","journal-title":"Meta Gene"},{"key":"2687_CR21","first-page":"1","volume":"7","author":"A Starosta","year":"2021","unstructured":"Starosta A, Konieczny P. Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy. Cell Mol Life Sci. 2021;7:1\u201325.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2687_CR22","first-page":"9","volume":"34","author":"A Taglia","year":"2015","unstructured":"Taglia A, Petillo R, D'AMBROSIO P, Picillo E, Torella A, Orsini C, et al. Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene. Acta Myologica. 2015;34(1):9.","journal-title":"Acta Myologica"},{"issue":"1","key":"2687_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JND-140002","volume":"1","author":"J Van den Bergen","year":"2014","unstructured":"Van den Bergen J, Ginjaar H, Niks E, Aartsma-Rus A, Verschuuren J. Prolonged ambulation in Duchenne patients with a mutation amenable to exon 44 skipping. J Neuromuscul Dis. 2014;1(1):91\u20134.","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"2687_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3988\/jcn.2017.13.1.91","volume":"13","author":"S Vengalil","year":"2017","unstructured":"Vengalil S, Preethish-Kumar V, Polavarapu K, Mahadevappa M, Sekar D, Purushottam M, et al. Duchenne muscular dystrophy and Becker muscular dystrophy confirmed by multiplex ligation-dependent probe amplification: genotype-phenotype correlation in a large cohort. J Clin Neurol. 2017;13(1):91\u20137.","journal-title":"J Clin Neurol"},{"key":"2687_CR25","doi-asserted-by":"crossref","unstructured":"Vieitez I, Gallano P, Gonz\u00e1lez-Quereda L, Borrego S, Marcos I, Mill\u00e1n J, et al. Espectro mutacional de la distrofia muscular de Duchenne en Espa\u00f1a: estudio de 284 casos. Neurolog\u00eda. 2017;32(6):377\u201385.","DOI":"10.1016\/j.nrl.2015.12.009"},{"issue":"8","key":"2687_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.nmd.2017.02.010","volume":"27","author":"D-N Wang","year":"2017","unstructured":"Wang D-N, Wang Z-Q, Yan L, He J, Lin M-T, Chen W-J, et al. Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China. Neuromuscul Disord. 2017;27(8):715\u201322.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"2687_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2350-14-29","volume":"14","author":"J Yang","year":"2013","unstructured":"Yang J, Li SY, Li YQ, Cao JQ, Feng SW, Wang YY, et al. MLPA-based genotype\u2013phenotype analysis in 1053 Chinese patients with DMD\/BMD. BMC Med Genet. 2013;14(1):29.","journal-title":"BMC Med Genet"},{"issue":"7","key":"2687_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.nmd.2016.05.004","volume":"26","author":"G Zamani","year":"2016","unstructured":"Zamani G, Heidari M, Malamiri RA, Ashrafi MR, Mohammadi M, Badv RS, et al. The quality of life in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2016;26(7):423\u20137.","journal-title":"Neuromuscul Disord"},{"key":"2687_CR29","doi-asserted-by":"crossref","unstructured":"Zamani G, Hosseini Bereshneh A, Azizi Malamiri R, Bagheri S, Moradi K, Ashrafi MR, et al. The first comprehensive cohort of the Duchenne muscular dystrophy in Iranian population: mutation Spectrum of 314 patients and identifying two novel nonsense mutations. J Mol Neurosci. 2020;70(10):1565\u201373.","DOI":"10.1007\/s12031-020-01594-9"},{"issue":"11","key":"2687_CR30","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s10072-015-2290-2","volume":"36","author":"GR Zamani","year":"2015","unstructured":"Zamani GR, Karami F, Mehdizadeh M, Movafagh A, Nilipour Y, Zamani M. Analysis of dystrophin gene in Iranian Duchenne and Becker muscular dystrophies patients and identification of a novel mutation. Neurol Sci. 2015;36(11):2011\u20137.","journal-title":"Neurol Sci"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02687-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T06:02:54Z","timestamp":1651557774000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02687-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2687"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02687-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"25 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee\/Institutional Review Board (IRB) of Tehran University of Medical Sciences (IRB code: IR.TUMS.CHMC.REC.1398.026). Written informed consent was obtained from all the patients and\/or their legal guardians, and all patients consciously participated in this study. All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all participants and\/or their legal guardian(s) for publication of their personal information\/images in an online open-access publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare no financial conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}